Deep brain stimulation for refractory temporal lobe epilepsy: a systematic review and meta-analysis with an emphasis on alleviation of seizure frequency outcome
- PMID: 28921161
- DOI: 10.1007/s00381-017-3596-6
Deep brain stimulation for refractory temporal lobe epilepsy: a systematic review and meta-analysis with an emphasis on alleviation of seizure frequency outcome
Abstract
Objective: Conflicting conclusions have been reported regarding predictors of deep brain stimulation (DBS) outcome in patients with refractory temporal lobe epilepsy (TLE). The main goal of this meta-analysis study was to identify possible predictors of remarkable seizure reduction (RSR).
Methods: We conducted a comprehensive search of English-language literature published since 1990 and indexed in PubMed, Embase, and the Cochrane Library that addressed seizure outcomes in patients who underwent DBS for refractory TLE. A pooled RSR rate was determined for eight included studies. RSR rates were analyzed relative to potential prognostic variables. Random- or fixed-effects models were used depending on the presence or absence of heterogeneity.
Results: The pooled RSR rate among 61 DBS-treated patients with TLE from 8 studies was 59%. Higher likelihood of RSR was found to be associated with lateralization of stimulation, lateralized ictal EEG findings, and a longer follow-up period. Seizure semiology, MRI abnormalities, and patient sex were not predictive of RSR rate. The best electrode type for RSR was the Medtronic 3389. Hippocampal and anterior thalamic nuclei (ATN) sites of stimulation had similar odds of producing RSR.
Conclusions: DBS is an effective therapeutic modality for intractable TLE, particularly in patients with lateralized EEG abnormalities and in patients treated on the ictal side. This meta-analysis provides evidence-based information for determining DBS suitability in presurgical counseling and for explaining seizure outcomes.
Keywords: Deep brain stimulation; Electrical stimulation of the brain; Meta-analysis; Temporal lobe epilepsy.
Similar articles
-
Seizure outcome after hippocampal deep brain stimulation in patients with refractory temporal lobe epilepsy: A prospective, controlled, randomized, double-blind study.Epilepsia. 2017 Oct;58(10):1728-1733. doi: 10.1111/epi.13860. Epub 2017 Jul 26. Epilepsia. 2017. PMID: 28744855 Clinical Trial.
-
Historical Risk Factors Associated with Seizure Outcome After Surgery for Drug-Resistant Mesial Temporal Lobe Epilepsy.World Neurosurg. 2016 May;89:78-83. doi: 10.1016/j.wneu.2016.02.023. Epub 2016 Feb 11. World Neurosurg. 2016. PMID: 26875655
-
Anterior nucleus of the thalamus deep brain stimulation vs temporal lobe responsive neurostimulation for temporal lobe epilepsy.Epilepsia. 2022 Sep;63(9):2290-2300. doi: 10.1111/epi.17331. Epub 2022 Jul 5. Epilepsia. 2022. PMID: 35704344 Free PMC article.
-
Deep brain stimulation for drug-resistant epilepsy.Epilepsia. 2018 Feb;59(2):273-290. doi: 10.1111/epi.13964. Epub 2017 Dec 7. Epilepsia. 2018. PMID: 29218702 Review.
-
Deep brain stimulation of hippocampus in treatment of refractory temporal lobe epilepsy.Neurol Neurochir Pol. 2024;58(4):393-404. doi: 10.5603/pjnns.99150. Epub 2024 Aug 2. Neurol Neurochir Pol. 2024. PMID: 39093168
Cited by
-
Temporal and extratemporal atrophic manifestation of temporal lobe epilepsy using voxel-based morphometry and corticometry: clinical application in lateralization of epileptogenic zone.Neurol Sci. 2021 Aug;42(8):3305-3325. doi: 10.1007/s10072-020-05003-2. Epub 2021 Jan 3. Neurol Sci. 2021. PMID: 33389247
-
Transcranial Focal Electrical Stimulation Modifies Biogenic Amines' Alterations Induced by 6-Hydroxydopamine in Rat Brain.Pharmaceuticals (Basel). 2021 Jul 21;14(8):706. doi: 10.3390/ph14080706. Pharmaceuticals (Basel). 2021. PMID: 34451804 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical